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Introduction
Recent global estimates found that stroke ranked as the second commonest cause of death with 5.9 million stroke-related deaths in 2010 [1] . This number is expected to increase to 7.8 million by 2030 in the absence of significant global public health response [2] . Despite the infectious disease scourge, low-and middle-income countries (LMICs) account for over 78% disability adjusted life years (DALYs) from stroke, which is at least 7 times the DALYs lost in high-income countries [1] . Disentangling the drivers of global mortality and morbidity has led to targeted regional and national investments in cardiovascular health resulting in about 40% reduction of stroke burden between 1970 and 2008 in high income countries [3] . Surprisingly, the trend is the opposite in LMICs with a rise of over 100% of stroke prevalence within the same period [3] . The increase and changing pattern of stroke prevalence in LMICs has mostly been attributed to rapid economic development and combined effects of demographic (particularly population growth and ageing), epidemiological and nutritional transitions currently occurring [4] . As the global population older than 65 years of age continues to increase by approximately 9 million people per year in LIMCs, this predicts a higher stroke prevalence with increase burden particularly in Asia and Latin America [5] .
Though there are existing reviews that had looked at prevalence of stroke in LMICs and regions such as Africa and Latin America [6] [7] [8] [9] , to the best of our knowledge there is no recent attempt to compile studies on stroke prevalence across different geographic regions in LMICs. Since the publication of these reviews, there have been an increasing number of new studies from these regions. This study therefore, aimed to provide more accurate estimates on the prevalence of stroke survivors and secular trends in LMICs in order to inform decision regarding policy responses and public health intervention across many geographic regions, socioeconomic and populations' subgroups.
Methods

Protocol and registration
This systematic review rational and methods were specified in advance and documented in a protocol which was published in the PROSPERO register (CRD42014015129) [10] 
Search strategy and data extraction
We conducted a thorough literature search to identify relevant studies on stroke prevalence in LMICs. Electronic databases of MEDLINE, EMBASE, SCOPUS and Web of Science were 4 searched from inception to July, 2015 without any language restriction. Relevant journals and reference lists of included primary articles were also scrutinized for additional studies that could have been omitted from the database searches. The following combinations of controlled review terms and keywords covering the study characteristics were used. These include: outcomes; "stroke", "cerebrovascular disease", "cerebrovascular accident", "brain infarction", "brain stem infarctions", "cerebral infarction," study design; "surveillance", "survey", "population based", "community based", and low-and middle-income countries; including all individual countries (Supplementary Table 1 ).
Data extraction and eligibility criteria
Three authors (ME, AE and EB) evaluated the eligibility of studies obtained from the literature search using a predefined protocol. They independently extracted, compared and merged the data on studies that met the selection criteria. In cases of discrepancy, agreement was reached by consensus. We included only community-based studies that reported prevalence of stroke 'survivors' and conducted in LMICs as defined by World Bank [11] . We also included only studies that used WHO's definition of stroke, ''rapidly developing clinical signs of focal (or global) disturbance of cerebral function lasting longer than 24 hour, unless interrupted by death, with no apparent cause other than that of vascular origin'' [12] , however, we allowed less rigorous case ascertainment due to inadequate facilities in most LMICs.
Studies that reported prevalence of stroke using some elements of the Sudlow-Warlow criteria [13] for stroke incidence were also included.
Assessment of methodological quality
Two authors (ME and AE) independently evaluated the methodological and reporting quality of each study using the modified version of Newcastle-Ottawa Scale (Supplementary Table   2 ). Essentially, we graded the risk of bias in each study as low, moderate, high or unclear according to five study areas namely; selection of participants (selection bias), sample size, detection instrument (outcome measurement tool), adjustment for confounding and (controlled) and detection accuracy. Publication bias using funnel plots and Egger's test was also conducted on the pooled studies 
Statistical analysis
For the meta-analysis, we first stabilized the raw prevalence of stroke from each study using the Freeman-Tukey variant of the arcsine square root transformed proportion [14] suitable for pooling. We used a DerSimonian-Laird random effects model [15] due to anticipated variations in study population, health care delivery systems and stage of epidemic transition.
We performed leave-one-study-out sensitivity analysis to determine the stability of the results. This analysis evaluated the influence of individual studies by estimating the pooled stroke prevalence in the absence of each study [16] . We assessed heterogeneity among studies by inspecting the forest plots and using the chi-squared test for heterogeneity with a 10% level of statistical significance, and using the I 2 statistic where we interpret a value of 50% as representing moderate heterogeneity [17, 18] . We assessed the possibility of publication bias by evaluating a funnel plot for asymmetry. Because graphical evaluation can be subjective, we also conducted a Egger's regression asymmetry test [19] as formal statistical tests for publication bias.
We explored the effect of study-level factors on the overall pooled stroke prevalence estimates using sub-group and meta-regression analyses. Univariate and multivariate randomeffects logistic regression analyses were conducted to investigate the impact of study-level factors on the pooled stroke prevalence. Univariate random-effects logistic regression analyses were used to investigate the bivariate relationship between each study-level factors and prevalence of stroke estimates. Multivariate random-effects logistic regression analyses were carried out to determine which study-level factors were independently associated with prevalence of stroke estimates. Only factors statistically significant in the univariate models were included in the multivariate model. Meta-analysis results were reported as combined stroke prevalence with 95% confidence intervals (CIs), while meta-regression results are reported as odds ratio with 95% CIs. All P values are exact and P<.05 was considered significant. Analyses were conducted using Stata version 14 for Windows (Stata Corp, College Station, Texas). This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline [20, 21] PRISMA checklist is provided in the Supplementary Table 3 .
Trend analysis
We examined time trends in the stroke prevalence estimates from 1970 to 2014 using Poisson regression models with the absolute cases of stroke as the outcome variable and the calendar 6 year of the publication as the predictor. This method allows for estimation of time trends across individual calendar years to obtain average annual percentage change (AAPC), assuming that the rate of change is at a constant rate of the previous year [22] . The Poisson regression procedure fits a model of the following form:
where 'cases' equals number of stroke cases reported per year, log is the natural log, b0 is the intercept, b1 is the trend, y is the year -year is given as 0, 1, 2, … 14 (year 0 is 1970, year 1 is 1971, and so on to 2014), and log of 'sample size' was entered as the offset. The AAPC was calculated using the following formula:
3. Results
Study selection and characteristics of the included studies
The process of study selection is shown in Fig.1 . Overall, the literature search of databases yielded 1,877 articles. The titles and abstracts of these were screened for relevance and 1,718
were excluded as duplicates, non-relevant titles and abstracts. 159 articles were selected for critical reading. In all, 101 articles with a total of 7,909,976 participants from 34 LMICs were included. The characteristics of the included studies are summarised in Supplementary Tables 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 7 82%). The median percentage of participants with known hypertension was 36% (range: 6 to 71%).
Risk of bias of included studies
Summary of risk of bias assessment for each study is shown in Supplementary Table 11 . The risk of bias in the selection of participants is low in most studies (n=98, 97%) and moderate in three studies (3%). The risk of bias due to sample size or number of participants included in the studies was low in most studies (n=83, 83%), high in seventeen studies (17%) and unclear in one study. The risk of detection bias due to inadequate outcome assessment was low, about three-quarter of the studies (n=77, 76%) and high in the remaining studies (n=24, 24%).
Variations in Stroke prevalence by geographical regions
East Asia and Pacific
Prevalence of stroke 'survivors' and 95% CIs from individual studies with a pooled estimate are shown in Fig.3 and Supplementary Fig. 1 . The reported stroke prevalence ranged from 4.27 (per 1000 population) to as much as 162 (per 1000 population). The pooled prevalence ('annualised year average') of stroke for all studies yielded an estimate of 19.9 (95% 14.7 to 25.9 per 1000 population). There was no evidence of publication bias (P = 0.058 for Egger's regression asymmetry test). The results of leave-one-study-out sensitivity analyses showed that no study had undue influence on pooled stroke prevalence ( Supplementary Fig. 3 ).
Europe and Central Asia
Prevalence of stroke 'survivors' and 95% CIs from individual studies with a pooled estimate are shown in Fig. 3 and Supplementary Fig. 4 . The reported stroke prevalence ranged from 9
per 1000 population in Turkey to 33 per 1000 population in Romania. The pooled prevalence ('annualised year average') of stroke for all studies yielded an estimate of 19.5 (95% 3.2 to 49.1 per 1000 population).
Latin America and Caribbean
Prevalence of stroke 'survivors' and 95% CIs from individual studies with a pooled estimate are shown in Fig. 3 and Supplementary Fig. 5 . The reported stroke prevalence ranged from 1.5 (per 1000 population) to as much as 54.2 (per 1000 population). The pooled prevalence ('annualised year average') of stroke for all studies yielded an estimate of 21.2 (95% 13.7 to 30.3 per 1000 population). There was no evidence of no evidence of publication bias (P = 0.053 for Egger's regression asymmetry test). The results of leave-one-study-out sensitivity 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 8 analyses showed that no study had undue influence on pooled stroke prevalence ( Supplementary Fig. 7 ).
Middle East and North Africa
Prevalence of stroke 'survivors' and 95% CIs from individual studies with a pooled estimate are shown in Fig. 3 and Supplementary Fig. 8 . The reported stroke prevalence ranged from 1.20 (per 1000 population) to 10.8 (per 1000 population). The pooled prevalence ('annualised year average') of stroke for all studies yielded an estimate of 5·6 (95% 4.0 to 7.5 per 1000 population). There was no evidence of publication bias (P = 0.917 for Egger's regression asymmetry test). The results of leave-one-study-out sensitivity analyses showed that no study had undue influence on pooled stroke prevalence ( Supplementary Fig. 10 ).
South Asia
Prevalence of stroke 'survivors' and 95% CIs from individual studies with a pooled estimate are shown in Fig.3 and Supplementary Fig. 11 . The reported stroke prevalence ranged from 0.5 (per 1000 population) to as much as 191 (per 1000 population). The pooled prevalence ('annualised year average') of stroke for all studies yielded an estimate of 9.4 (95% 6.7 to 12.6 per 1000 population). There was no evidence of publication bias (P = 0.928 for Egger's regression asymmetry test). The results of leave-one-study-out sensitivity analyses showed that no study had undue influence on pooled stroke prevalence ( Supplementary Fig. 13 ).
Sub-Saharan Africa
Prevalence of stroke 'survivors' and 95% CIs from individual studies with a pooled estimate are shown in Fig. 3 and Supplementary Fig. 14 . The reported stroke prevalence ranged from 0.15 (per 1000 population) to as much as 24.2 (per 1000 population). The pooled prevalence ('annualised year average') of stroke for all studies yielded an estimate of 3.5 (95% 1.9 to 5.7
per 1000 population). There was no evidence of publication bias (P = 0.945 for Egger's regression asymmetry test). The results of leave-one-study-out sensitivity analyses showed that no study had undue influence on pooled stroke prevalence ( Supplementary Fig. 16 ).
Variations in Stroke prevalence by country's income categories
As shown in Fig. 3 , the pooled prevalence stroke 'survivors' was highest in upper-middle income countries (20.9, 95% CI 17.0 to 25.2 per 1000, 57 studies) followed by lower middle-income countries (6.9, 95% CI 5.4 to 8.6 per 1000, 37 studies) and closely by lowincome countries (6.0, 95% CI 2.1 to 11.8 per 1000, 7 studies). 
Factors modifying prevalence of stroke estimates
The result of study-level factors associated with prevalence of stroke is shown in Table 1 . In the adjusted analyses, study's geographic region, income category, publication year, participants' mean age, and percentage male were statistically significantly associated with stroke prevalence estimates. Prevalence estimates from East Asia and Pacific and Latin America and Caribbean were six times higher than those from sub-Saharan Africa. Similarly, stroke prevalence from upper-middle income countries was as four times as high as those from low-income countries. Stroke prevalence from urban areas was twice as high as those from rural areas. For every 10 years increase in participants' mean age, the stroke prevalence increases by 84% (OR = 1.84, 95% CI 1.46 to 2.32) (Supplementary Fig. 18 ). For every 10% increase in the percentage of male participants included in the study, the stroke prevalence decreases by 68% (OR = 0.32, 95% CI 0.22 to 0.47) (Supplementary Fig. 19 ). Variations in the mean age of the participants explained almost half of the between studies variation in stroke prevalence estimates (49%).
Year of publication, percentage male, and sample size each explained almost one-third in the between studies variation in stroke prevalence estimates. However, in the adjusted analysis, when all study-level factors that were significant in unadjusted analyses were controlled for 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 statistically, only mean age of the participants remained statistically significant with the prevalence of stroke estimates (OR-1.62, 95% CI 1.06 to 2.47).
Discussion
Stroke prevalence varied significantly across geographical regions in different time period.
Low-income countries particularly in sub-Saharan African have low prevalence of stroke survivors. This may have been due to the high fatality rates from stroke owing to less investment in health care, increased poverty and co-morbidities like HIV/AIDS and Tuberculosis [26] [27] [28] . The early stage of epidemiological transition characterised by hypertensive heart disease and a huge proportion of haemorrhagic stroke disease are now occurring in these countries [29] . Pooled estimate of stroke in upper-middle-income countries is about 3-fold higher as against lower-middle-income or low-income countries. These differences are not surprising, however, the increasing levels of affluence and urbanization [30] and the rise in life expectancy [30] and associated risk factors [4, 25] particularly hypertension provide a plausible explanation. In fact, there is a large body of epidemiological evidence on the high prevalence of undetected or poorly managed hypertension in LMICs, which is likely to play a major role in the huge prevalence of stroke in these settings [25] .
We observed a continuous increase in the stroke prevalence across the three countries' income categories. Over the past three decades, the stroke prevalence has increased annually by 14.3% (trend = 0.134, p value = 0.0001) in low-incomes countries, 12% in upper-middle income countries (trend = 0.113, p value = 0.0001) and by 5.8% in lower-middle income countries (trend = 0.057, p value = 0.0001). Though, the prevalence of stroke has been highest in upper-middle income countries, however, low-income countries record the steepest increase in stroke prevalence and projected to overtake both lower-middle and upper-middle-income countries. The changing prevalence of stroke survivors is quite revealing, and suggests a major epidemiological and demographic shift. Other common themes found within the periods indicate a low prevalent rate from 1970-1989, however, there are few exceptions where the rate had increased significantly and reached a plateau from 1983 and 1988 [31] [32] [33] . Between 1990 and 2007, data from China [34] , Columbia [35, 36] and Romania [37] showed a net increase in prevalence. This increases several folds from 2010 to 2014 particularly in China [32, 38, 39] Brazil [30, 40, 41] and Cuba [42] , suggesting a combination of rapid socioeconomic changes including increase in aging population ,   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11 urbanization, and lifestyle factors. Latin America faces major demographic changes; the most important being urbanization (almost 90% of the population now live in urban areas) and aging; that is, the ratio of productive adults to elderly individuals is steadily shrinking [5, 8] . In Brazil for instance, socio-economic developments that have occurred over the past decades is well-known. Other factors may include access to vascular prevention strategies, exposure to risk factors and inequality to basic medical care particularly in the rural communities [41] .
This review apart from the evidentiary underpinning of the significantly higher prevalence of stroke, revealed some important issues including the preponderance of traditional risk factors. For every 10 years increase in participants' mean age, the stroke prevalence increases by 62%. The pattern of age-specific increase in stroke prevalence is clearly marked within three age-brackets for both genders with available data. Our result show that Latin America and Caribbean region has the highest proportion of elderly (≥65 years) participants living in urban areas.
This corroborated the recent evidence of epidemiological transition in Latin America toward older urban dwelling adults [8] . The higher proportion of stroke in upper-middle-income countries and urban settings compared to low-income countries and rural environments as shown in the present study and in previous reviews [6, 8, 43] are in line with convergence of increasing income level, urbanisation and cardio-vascular disease predictors.
The most recent reviews on stroke epidemiology were limited to 7 incidence studies in 9
LMICs [9] . Previous reviews had little representation of LMICs [44] , others were based on regional [6, 8, [45] [46] [47] [48] , country [28, 49, 50] or population-specific analysis [28, 49, 50] . There are also global reviews of stroke with few studies in LMICs [1, 44] . Given the limited number of studies, geographical spreads and omission of important development indicators, it appears that these reports may not necessarily reflect the true prevalence estimate of stroke survivors in LMICs in the current epidemiological and demographic transitions. For instance, Feign and co-authors (2014), in a recent report on the global burden of stroke reported a prevalence estimates of 393.4/100,000 population in 2010 [1] . The result was comparable with the current estimate, which further underpins a near representation of the size of the problem in LMICs. However, the minor differences may probably be due to the study periods, age groups and fewer data-points (the report provided data for only 34 populationstudies for LMICs). In addition, the result of stroke prevalence in Africa reported a continent-
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wide pooled estimate without due consideration of human development index and gross national income per capita estimates [6, 51] . Our study presents the most comprehensive and up-to-date review of stroke prevalence in LMICs. Moreover, the introduction of World Bank regions and income groups in our analytical model provided interesting dimension to warrant valid comparative estimate appropriate for public health policy interventions on the prevalence of stroke survivors within these jurisdictions.
To date, the health priorities of many LMICs particularly in sub-Saharan Africa and south
Asian countries remain infectious diseases mainly HIV/AIDS, Malaria and Tuberculosis [52] [53] [54] . This is in addition to high poverty, malnutrition, illiteracy, unsafe drinking water and social discrimination [55] . The economic impact of increased stroke survivors in our study would mean growing underinvestment and GDP loses reflecting increased loss in productivity and reduced labour efficiency in LMICs.
Cost for stroke survivors was estimated to be as high as $34 billion annually in the United
States [56] , and about 5% of total NHS cost amounting to £8.9billion in the UK [57] . Studies on the cost of stroke in LMICs are few and far between, in Togo for instance, the estimated direct cost per person stood at 936 Euros in only 17 days, about 170 times more than the average annual heath expenditure of a Togolese [58] . This does not include informal and indirect costs. Such financial outlay in stroke alone would foreclose the consideration of urgent priority public health issues in LMICs.
Consistent evidence from our study and elsewhere found that hypertension is the main risk factor of all stroke in LMICs and this is more prominent among the young adults who present with stroke unaware of their high blood pressure status [59] . With the steepest increase in the prevalence of stroke survivors taking place in LMICs particularly in low-income countries, options for urgent and improved surveillance and cost-effective prevention of major riskfactors such as hypertension remain an important public health priority. As a result of the double burden of communicable and non-communicable diseases in LMICs [60] , it appears the estimates found in this study will continue in an upward trend with huge fatality due to policy alignment focusing on the prevention and control of infectious diseases including maternal, perinatal and nutrition related conditions.
While informative, the results of this meta-analysis should be interpreted with caution.
First, in large continental region such as sub-Saharan Africa and Europe and Central Asia ,   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 13 there were insufficient studies to entirely represent the regions. In addition, we found significant difference related to study-level participants' characteristics, publication year, and study sample size. Nevertheless, the results of tests for publication bias provided evidence that we are unlikely to have missed studies that could have altered the metaanalyses results. The diagnosis of stroke in LMICs remains a huge challenge, hence, ascertainment of cases were not well defined across some studies and this has been reported previously [61] . We did not provide data on stroke-related disability or casefatality. Although such data are important for health-care planning, such estimates may be unreliable due to conflicting information on causes of death, overlapping disabilities caused by disorders that accompany stroke in many older patients and the fact that majority of stroke survivors do not access the health service due to prohibitive out-of-pocket expenses, distance to urban hospital and lack of stroke functioning units in rural health care settings [44, 62] . Some hospital surveys in south Asia and sub-Saharan Africa have shown that CT scans for instance, were only conducted on less than half of patients presenting with stroke, and this is mainly among those that can afford it [62] . Nonetheless, we allowed studies showing quality methodological rigour including detailed epidemiological exercise in our final analysis.
Despite these limitations, the study's strengths are important. We conducted a meta-analysis as a preferable option for data synthesis, since qualitative or narrative synthesis can lead to misleading conclusions that should not be generalized beyond the scope of the analysis [63] .
Comprehensive searches of databases were also conducted to ensure that all relevant publications were identified. We also reduced potential bias in the conduct of this review by having the authors independently scan through the search output and extract the data. In addition, we included only community-based studies and provided estimates on stroke prevalence trends. These provided additional information for local feedback on health system and public-health demands.
Conclusions
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